Hidekazu Shirota

11PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer geneticsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 07, 2026
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

|Oct 06, 2025
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report.

Maako Kawamura, Hiroshi Tada, Hidekazu Shirota

|Aug 14, 2025
Plasma Lysophosphatidylcholine Levels Correlate with Prognosis and Immunotherapy Response in Squamous Cell Carcinoma.

Tomoyuki Iwasaki, Hidekazu Shirota, Eiji Hishinuma

|Apr 18, 2025
Regional Differences in the Frequency of BRCA1 and BRCA2 Variants in Northeastern Japan: A Cohort Study.

Hidekazu Shirota, Akimitsu Miyake, Maako Kawamura

|Jan 05, 2025
Comprehensive Genome Profiling-Initiated Tumor-Informed Circulating Tumor DNA Monitoring for Patients With Advanced Cancer.

Taiga Sasaki, Hayato Hiraki, Akiko Yashima-Abo

|Sep 26, 2024
Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: A retrospective cohort study.

Tomoyuki Iwasaki, Hidekazu Shirota, Keiju Sasaki

Pageof 2

Frequent Collaborators

5 joint publications

Chikashi Ishioka

3 joint publications

Manabu Muto

2 joint publications

Hidenori Kage

2 joint publications

Akira Hirasawa